Drug regulators cancel licences of drug manufacturing units over quality concerns
New Delhi: The central and state drug regulatory bodies have banned the licences of numerous production facilities and revoked the product approvals of a few others, all on the grounds of quality concerns. Regulators investigated dozens of medication manufacturing plants in Himachal Pradesh, Uttarakhand, Haryana, Madhya Pradesh, and Maharashtra in response to allegations of the […] More